UK pharma group Vectura agrees $1.4 billion takeover by Carlyle

Vectura's Chairman Bruno Angelici said the company had made strong progress since embarking on a strategy in 2019 to become a leading inhalation-focused CDMO, or contract development and manufacturing organisation.

from International-News-Economic Times https://ift.tt/3vrdp7N
via IFTTT

SHARE